Evidence map›Paper›PMID 31785146›Full record

ArticleAging2019

T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenarians.

Ainhoa Alberro, Iñaki Osorio-Querejeta, Lucía Sepúlveda, Gorka Fernández-Eulate, Maider Mateo-Abad, Maider Muñoz-Culla, Susana Carregal-Romero, Ander Matheu, Itziar Vergara, Adolfo López de Munain and 2 more

Open access · greenAbstract read
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Extracellular Vesicles in Blood: Sources, Effects, and Applications.International journal of molecular sciences · 2021
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Ainhoa AlberroBiodonostia Health Research Institute, Multiple Sclerosis Group, San Sebastian, Spain.
Iñaki Osorio-QuerejetaBiodonostia Health Research Institute, Multiple Sclerosis Group, San Sebastian, Spain.
Lucía SepúlvedaBiodonostia Health Research Institute, Multiple Sclerosis Group, San Sebastian, Spain.
Gorka Fernández-EulateOsakidetza Basque Health Service, Donostia University Hospital, San Sebastian, Spain.
Maider Mateo-AbadBiodonostia Health Research Institute, Primary Care Unit, San Sebastian, Spain.
Maider Muñoz-CullaBiodonostia Health Research Institute, Multiple Sclerosis Group, San Sebastian, Spain.
Susana Carregal-RomeroCIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Ander MatheuBiodonostia Health Research Institute, Cellular Oncology Group, San Sebastian, Spain.
Itziar VergaraBiodonostia Health Research Institute, Primary Care Unit, San Sebastian, Spain.
Adolfo López de MunainOsakidetza Basque Health Service, Donostia University Hospital, San Sebastian, Spain.
Matías Sáenz-CuestaBiodonostia Health Research Institute, Multiple Sclerosis Group, San Sebastian, Spain.
David OtaeguiBiodonostia Health Research Institute, Multiple Sclerosis Group, San Sebastian, Spain.
Biogipuzkoa Health Research Institute · ESSpanish Multiple Sclerosis Network · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESSpanish Clinical Research Network · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is a universal and complex process that affects all tissues and cells types, including immune cells, in a process known as immunosenescence. However, many aspects of immunosenescence are not completely understood, as the characteristics of the immune cells of nonagenarians and centenarians or the features and implications of extracellular vesicles (EVs). In this study, we analyzed blood samples from 51 individuals aged 20-49 and 70-104 years. We found that senescent CD8 cells accumulate with age, while there is a partial reduction of senescent CD4 cells in nonagenarians and centenarians. Moreover, plasma EVs carry T cell specific markers, but no accumulation of "senescent-like EVs" was found within any of analyzed age groups. Our functional studies of cocultures of peripheral blood mononuclear cells and EVs showed that EVs enhance T cell viability and, under phytohemagglutinin stimulation, they influence cytokine secretion and cell activation in an age-dependent manner. These results underline the importance of EVs on the immune system functioning, and open new perspectives to further study their implication in human aging.

Indexed as

AdultAgedAged, 80 and overExtracellular VesiclesFemaleHumansImmunosenescenceLymphocyte ActivationMaleMiddle AgedT-Lymphocytesagingcentenariansextracellular vesicles (EVs)immunosenescenceT cells

Identifiers

PMID31785146
PMCPMC6914389
OpenAlexW2990297624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.